sodium-dependent glucose transporters 2 group:None

2 trials

Sponsors

West China Hospital, Sichuan University

Conditions

diabetic kidney diseasetype 2 diabetes mellitus and chronic kidney disease

Early Phase 1

The efficacy and safety of SGLT2 inhibitors on patients with type 2 diabetes mellitus combined with chronic kidney disease

Active, not recruitingChiCTR2300072845

West China Hospital, Sichuan Universitytype 2 diabetes mellitus and chronic kidney disease

Start: 2023-01-10Updated: 2023-07-10

Unknown Phase

A real-world study based on the analysis of the current status, efficacy, and safety of glucose-lowering regimens in outpatients and inpatients with diabetic kidney disease in West China Hospital, Sichuan University

RecruitingChiCTR2300068497

West China Hospital, Sichuan Universitydiabetic kidney disease

Start: 2023-03-01Updated: 2023-05-22

Related Papers

Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China

Frontiers in Pharmacology2024-12-033 citations